News
From US president Donald Trump to Tesla CEO Elon Musk, Time Magazine's 100 Most Influential People of 2025 list included some ...
Fans are speculating whether Oprah Winfrey is showing signs of a surprising new weight-loss drug side effect known as ...
Leaders We Deserve, a group led by David Hogg, announced it will spend $20 million to help younger candidates and primary ...
TIME's 2025 list of the 100 Most Influential People includes global figures like Donald Trump and Muhammad Yunus in the ...
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy ...
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...
Scilex (SCLX) announced that FDA has approved the company’s request for the orphan drug designation for colchicine for the treatment of ...
Brainstorm Cell Therapeutics is seeking FDA clearances to launch a Phase 3b clinical trial to test its NurOwn stem cell therapy for ALS.
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
The Trump administration plans to slash annual discretionary spending at the US federal health department by around one-third ...
Regeneron Pharmaceuticals ( NASDAQ: REGN) said on Thursday that the U.S. FDA will be reviewing the supplemental biologics license application ( (sBLA)) for Eylea HD injection, 8 mg, to treat macular ...
U.S. President Donald Trump on Tuesday signed an executive order that aims to delay Medicare negotiations for a broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results